Clinical Trial Update: Droxidopa / Pyridostigmine in Orthostatic Hypotension [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study evaluating droxidopa and pyridostigmine in orthostatic hypotension, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Orthostatic Hypotension

Drugs mentioned

• Mestinon (pyridostigmine bromide)
• Northera (droxidopa)

Snippet

Sponsor: Mayo Clinic | Conditions: Orthostatic Hypotension | Phase 2 | Status: ENROLLING_BY_INVITATION